(Q44957832)

7 December 2017

1 reference

title

The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis (English)

1 reference

7 December 2017

1 reference

1 reference

4

Jaume Marrugat

1 reference

7 December 2017

Marta Tomás

1

1 reference

7 December 2017

Glòria Latorre

series ordinal

2

1 reference

7 December 2017

Mariano Sentí

series ordinal

3

1 reference

7 December 2017

language of work or name

Spanish

0 references

publication date

1 June 2004

1 reference

Revista Española de Cardiología

7 December 2017

published in

1 reference

7 December 2017

volume

57

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

557-569

1 reference

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

[Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Anthropometric and dietary determinants of blood levels of HDL cholesterol in a population-based study. The REGICOR study. Researchers of the REGICOR study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Apolipoprotein J is associated with paraoxonase in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Hydrolysis of platelet-activating factor by human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Pharmacogenomic considerations of the paraoxonase polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase gene polymorphism and coronary artery disease in Indian subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Absence of "A"-esterase activity in the serum of a patient with Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Vaccines against human cytomegalovirus: time to test

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Symptoms of chronic bronchitis and the risk of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Excess deaths attributable to influenza in England and Wales: age at death and certified cause

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity decreases in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

High oxidative stress in patients with stable coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Antioxidant paraoxonase 1 activity in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with s

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Vitamin C and E intake is associated with increased paraoxonase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Simvastatin decreases aldehyde production derived from lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effects of fibrates on serum metabolic parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Glycation impairs high-density lipoprotein function

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase in Persian Gulf War veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Serum paraoxonase and arylesterase activities in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase Polymorphism (Gln192-Arg) Is Associated with Coronary Heart Disease in Japanese Noninsulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Genetic polymorphism of paraoxonase and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Genetic factors associated with the absence of atherosclerosis in octogenarians

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977146-8

7 January 2021

10.1016/S0300-8932(04)77146-8

Identifiers

DOI

1 reference

7 December 2017

1 reference